Internet Archive Scholar

Consensus clinical management guidelines for Acid Sphingomyelinase Deficiency (Niemann-Pick disease types A, B and A/B) [post]

Tarekegn Geberhiwot, Melissa Wasserstein, Subadra Wanninayake, Shaun Christopher Bolton, Andrea Dardis, Anna Lehman, Oliver Lidove, Charlotte Dawson, Roberto Giugliani, Jackie Imrie, Justin Hopkin, James Green (+10 others)
2022 unpublished

Preserved Fulltext

fulltext thumbnail
Web Archive Capture PDF (1.4 MB)
https://web.archive.org/web/20221219041523/https://assets.researchsquare.com/files/rs-2206440/v1/cd1105cf-f870-4d38-ae3d-9f783a016ba1.pdf?c=1671423176

A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL. The file type is application/pdf.

Background: Acid sphingomyelinase deficiency (ASMD) is a rare autosomal recessive disorder caused by mutations in SMPD1 gene. This rarity contributes to misdiagnosis, delayed diagnosis and barriers to good care. There is no published national or international guideline for diagnosis and management of patients with ASMD. For these reasons, we at INPDR have developed a clinical guideline that define standard of care for ASMD patients Methods: The information contained in these guidelines was
more » ... ned through a systematic review of the literature and the experiences of the authors in their care of patients with ASMD. We adopted the Appraisal of Guidelines for Research & Evaluation (AGREE II) system as method of choice for the guideline development process. Results: The clinical spectrum of ASMD, although a continuum, varies substantially with subtypes ranging from a fatal infantile neurovisceral disorder to an adult-onset chronic visceral disease. We made 39 conclusive statements and scored them according to level of evidence, strengths of recommendations and expert opinions. In addition, this guideline has identified gaps in the knowledge that must be filled by future research. Conclusion: This guideline can inform care providers, care funders, patients and their carers about best clinical practice and lead to a step change in the quality of care for patients with ASMD.
doi:10.21203/rs.3.rs-2206440/v1 fatcat:kqjiy34oq5gyjghprejfzcae44
Open Access
Citation

Tarekegn Geberhiwot, Melissa Wasserstein, Subadra Wanninayake, Shaun Christopher Bolton, Andrea Dardis, Anna Lehman, Oliver Lidove, Charlotte Dawson, Roberto Giugliani, Jackie Imrie, Justin Hopkin, James Green, Daniel de Vicente Corbeira, Shyam Madathil, Eugen Mengel, Fatih Ezgu, Magali Pettazzoni, Barbara Sjouke, Carla Hollak, Marie T Vanier, Margaret McGovern, Edward Schuchman. "Consensus clinical management guidelines for Acid Sphingomyelinase Deficiency (Niemann-Pick disease types A, B and A/B)." (2022)